LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q2 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $435.35 million versus the consensus estimate of $414.38 million.

FY 2026 Guidance:-

Revenue between $1.685 billion to $1.725 billion vs consensus $1.66 billion.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.